Overacre-Delgoffe, Abigail E.
University of Pittsburgh · Children's Hospital of Pittsburgh · University of Pittsburgh Medical Center
4 papers on CoChatORCID 0000-0003-4027-3487
Most cited papers
- Verified
Interferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity
Overacre-Delgoffe, A. E., Chikina, M., Dadey, R. E., Yano, H., Brunazzi, E. A., Shayan, G., Horne, W., Moskovitz, J. M., Kolls, J. K., Sander, C., et al. (2017) · Cell
T-cell and B-cell ImmunologyCancer Immunotherapy and Biomarkers
Cited by 627
- Verified
Microbiota-specific T follicular helper cells drive tertiary lymphoid structures and anti-tumor immunity against colorectal cancer
Overacre-Delgoffe, A. E., Bumgarner, H. J., Cillo, A. R., Burr, A. H. P., Tometich, J. T., Bhattacharjee, A., Bruno, T. C., Vignali, D. A. A., & Hand, T. W. (2021) · Immunity
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 318
- Verified
Considerations for treatment duration in responders to immune checkpoint inhibitors
Marron, T. U., Ryan, A. E., Reddy, S. M., Kaczanowska, S., Younis, R. H., Thakkar, D., Zhang, J., Bartkowiak, T., Howard, R., Anderson, K. G., et al. (2021) · Journal for ImmunoTherapy of Cancer
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 137
- Verified
Treg Fragility: A Prerequisite for Effective Antitumor Immunity?
Overacre-Delgoffe, A. E., & Vignali, D. A. A. (2018) · Cancer Immunology Research
T-cell and B-cell ImmunologyCancer Immunotherapy and Biomarkers
Cited by 102
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free